SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) |
| March 30, 2004 |
MACROPORE BIOSURGERY, INC.
(Exact name of registrant as specified in Charter)
Delaware |
| 000-32501 |
| 33-0827593 |
(State or Other Jurisdiction |
| (Commission File |
| (IRS Employer |
|
|
|
|
|
6740 Top Gun Street, San Diego, California |
| 92121 | ||
(Address of Principal Executive Offices) |
| (Zip Code) | ||
|
|
|
|
|
Registrant’s telephone number, including area code: (858) 458-0900 |
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit 99.1 |
| Press release issued by MacroPore Biosurgery, Inc. on March 30, 2004, announcing financial results for the fiscal year and quarter ended December 31, 2003. |
Item 12. Results of Operations and Financial Conditions.
MacroPore Biosurgery, Inc. reported financial results for the fiscal year and quarter ended December 31, 2003, in a press release dated March 30, 2004, attached hereto as Exhibit 99.1.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| MACROPORE BIOSURGERY, INC. | |||
|
|
| |||
|
|
| |||
Dated: March 30, 2004 |
| By: | /s/ Christopher J. Calhoun |
| |
|
|
|
| Christopher J. Calhoun | |
|
|
|
| President and Chief Executive Office | |
2
EXHIBIT INDEX
Exhibit Number |
|
|
|
|
|
99.1 |
| Press release issued by MacroPore Biosurgery, Inc., on March 30, 2004, announcing financial results for the fiscal year and quarter ended December 31, 2003. |
3